cAMP is a key player in the intracellular signaling pathways of hormones, neurotransmitters, odorants, and chemokines. By activating PKA and cyclic nucleotide-gated ion channels, this protean second messenger can change cellular attributes as diverse as the membrane potential and the rate of cell division. The key step in regulating intracellular cAMP is modulation of adenylyl cyclase activity. Adenylyl cyclase, the enzyme that synthesizes cAMP, is subject to coincident regulation by both extracellular and intracellular stimuli. After the original cloning of the mammalian adenylyl cyclase gene by Krupinski et al. (1989) , at least nine isoforms of mammalian adenylyl cyclases have been cloned and analyzed, revealing diverse regulation by G proteins, Ca 2ϩ , and phosphorylation (reviewed in Sunahara et al., 1996 , and a monograph edited by Cooper, 1997) . Historically, extensive biochemical analysis has been hampered by the inability to express and purify cyclase in its native, membrane-bound form. Fortunately, the catalytic core domains of adenylyl cyclase can be used to construct a soluble enzyme that maintains sensitivity to its physiological regulators and can be expressed in useful levels in Escherichia coli . This soluble enzyme has a turnover number (ranging from 4 to 100 sec Ϫ1 ) comparable to or greater than the maximal activity of the membrane-bound enzyme Whisnant et al., 1996; Yan et al., 1996; Scholich et al., 1997; Sunahara et al., 1997) . It has emerged as an extraordinarily useful model for studying the biochemical mechanisms of catalysis and regulation of fulllength mammalian adenylyl cyclases. In this review, we focus on how adenylyl cyclase catalyzes the formation of cAMP from ATP in response to its regulators. For the first time, this can be addressed in molecular detail using the recently solved structures of adenylyl cyclase associated with or without its stimulatory G protein and product analogs (Zhang et al., 1997b; Tesmer et al., 1997) .
Catalytic Core of Adenylyl Cyclase
Extracellular signals (i.e., hormones, neurotransmitters, odorants, and autocrines) require at least three membrane components to modulate intracellular cAMP: a heptahelical receptor, a heterotrimeric G protein, and adenylyl cyclase. The main stimulatory effect of adenylyl cyclase by hormones and neurotransmitters is mediated by G s␣ , the ␣ subunit of G s protein that stimulates adenylyl cyclase. Although each of the nine isoforms (types I-IX) of mammalian adenylyl cyclases has its unique and diverse regulation (Table 1) , they share a common structure: two cytoplasmic domains (C 1 and C 2 ), each following a transmembrane stretch that hypothetically has six ␣-helices (M 1 and M 2 ) (Fig. 1 ). The C 1 and C 2 domains have ϳ230 amino acid regions (C 1a and C 2a ) that share 50% or high similarity and form the catalytic core (Fig.  2 ). Systematic mutational analysis has shown that the amino acid residues from both C 1a and C 2a domains contribute to ATP binding and catalysis Yan et al., 1997b) . Truncation analysis has permitted expression and high yield purification of G s␣ -regulated, soluble enzymes using only C 1a and C 2a domains, from either the same or different mammalian adenylyl cyclases Dessauer and Gilman, 1996; Whisnant et al., 1996; Yan et al., 1996 Yan et al., , 1998 Scholich et al., 1997; Sunahara et al., 1997) . Such soluble enzymes also can be activated by the diterpene forskolin, derived from the root of the Indian plant Coleus forskolhii (Seamon and Daly, 1986) .
The tertiary structure of the cyclase domain has been elucidated by the structure of a nearly inactive C 2a homodimer of type II adenylyl cyclase (IIC 2 ) (Zhang et al., 1997a (Zhang et al., , 1997b and the fully active, heterodimeric combination of type V C 1a and type II C 2a (Tesmer et al., 1997) . As expected from the high homology between C 1a and C 2a , their tertiary structures This work was supported by National Institutes of Health Grant GM53459.
are almost identical, consisting of a three-layer ␣/␤ sandwich with the C 1a and C 2a domains arranged in head-to-tail fashion as a wreath (Fig. 3, A and B) . The cyclase domain contains a ␤␣␤␤␣␤ substructure that resembles the palm domains of the polymerase I family of prokaryotic DNA polymerase, including E. coli DNA polymerase I and Thermus aquaticus (Taq) polymerase. The interface of C 1a and C 2a domains can accommodate two potential ATP binding sites (Fig. 3, A and B) . Only one of the sites consists of crucial residues for catalysis and binds substrate, whereas the other is the site for the binding of forskolin Liu et al., 1997; Tesmer et al., 1997; Yan et al., 1997b Yan et al., , 1998 .
The wreathlike dimer arrangement is likely to exist in other enzymes that perform the same or similar reaction ( Fig. 1 ; reviewed in Tang et al., 1997) . These include many homologous adenylyl cyclases and guanylyl cyclases (enzymes that convert GTP to cGMP). An integral membrane adenylyl cyclase that has six putative transmembrane-helices is found in Mycobacteria (MtAC). One transmembranehelix form of adenylyl cyclases occurs in parasites (TbESAG and LdRAC) and in slime mold (DdACG). The family of membrane-bound receptor guanylyl cyclase from mammals (GC A-G), fruit fly (DmGC), sea urchin (SpGC), and nematode (CeGC) is growing rapidly (Yu et al., 1997 , and references therein). There are peripheral membrane adenylyl cyclases from yeast and soluble adenylyl cyclases from bacteria and plant (BlAC, RmAC, Tobacco axi). Although not determined experimentally, cyclases with the homodimeric cyclase domain are predicted to have two NTP binding sites, consistent with positive cooperativity of membrane-bound guanylyl cyclase with respect to GTP (Wedel et al., 1997; Liu et al., 1997) . NO-activated soluble guanylyl cyclases consist of ␣ and ␤ subunits that are homologous to C 1a and C 2a of mammalian adenylyl cyclase (Hobbs, 1997) . The C 1a /C 2a structure is unlikely to apply to the energy state-regulated adenylyl cyclases from Enterobacteria and the calmodulinsensitive adenylyl cyclase/toxins from Bacillus anthracis and Bordetella pertussis because no sequence similarity can be detected among them (Tang et al., 1997, and references therein) .
Structure of the G s␣ and Forskolin Binding Sites of Mammalian Adenylyl Cyclases
Many neurotransmitters and hormones (i.e., epinephrine, dopamine, and luteinizing hormone) activate G s -coupled receptors, leading to stimulation of mammalian adenylyl cyclase by GTP-G s␣ at a picomolar concentration. Although G s␣ is palmitoylated, the high affinity of G s␣ for adenylyl cyclase is likely to depend on another unidentified lipid modification (Linder et al., 1993; Kleuss and Gilman, 1997) . The G s␣ binding site of adenylyl cyclase has been localized to a small region of C 1a (amino terminus) and a much larger negatively charged and hydrophobic groove on C 2a (␣2 and ␣3/␤4) by mutagenic mapping (Yan et al., 1997a) . The G s␣ binding site is ϳ30 Å away from the catalytic site ( Fig. 3C) (Yan et al., 1997a; Tesmer et al., 1997) . The adenylyl cyclase binding site of G s␣ also has been mapped to switch 2 (␣2) and the loop regions of ␣3/␤5 and ␣4/␤6; only switch 2 region changes conformation on the binding of GTP (Berlot and Bourne, 1992; Lambright et al., 1994) . Gao and Gilman, 1991; Yoshimura et al., 1996; Chen et al. 1995 Cali et al., 1994; Vorherr et al., 1993; Wu et al., 1993 PKC II, V, VII ϩ ACII (1034-1068, Thr 1057) Kawabe et al., 1994; Jacobowitz and Iyengar, 1994; Yoshimura et al. 1993; Zimmermann and Taussig, 1996; Levin and Reed, 1995; Bol et al. 1997 
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The crystal structure of VC 1 /IIC 2 /G s␣ reveals the molecular nature of the G s␣ /adenylyl cyclase interaction (Tesmer et al., 1997) . The interface between adenylyl cyclase and G s␣ is substantial (1800 Å 2 ), and switch 2 is a major component of the adenylyl cyclase binding site of G s␣ (Tesmer et al., 1997) . The main contact between C 1 and G s␣ is the hydrophobic interaction between AC1 F293 and G s␣ W281 (Tesmer et al., 1997; Yan et al., 1997a) . The C 2 /G s␣ interaction is both polar (negative in C 2 and positive in G s␣ ) and hydrophobic (Tesmer et al., 1997; Yan et al., 1997a) . Kinetic analysis has suggested more than one G s␣ binding sites based on the biphasic activation of type VI enzyme by G s␣ , and the low affinity site of type VI enzyme seems to be blocked by a peptide from the C 1b region (Chen et al., 1997) . This putative G s␣ binding site at the C 1b region may play a role in interacting with the region that is not involved in the contact between C 1a /C 2a and G s␣ in the VC 1 /IIC 2 /G s␣ structure (i.e., ␣4/␤6, which is 10 Å away from C 1a /C 2a ; Tesmer et al., 1997) .
Forskolin, a hypotensive diterpene, has been profoundly useful as a pharmacological probe for adenylyl cyclase function in vivo and in vitro (Seamon and Daly, 1986) . Forskolin binds to only one site on the C 1 /C 2 heterodimer, which is virtually identical to the two nearly symmetric sites on the IIC 2 homodimer (Dessauer et al., 1997a; Tesmer et al., 1997; Zhang et al., 1997b) . Interactions between forskolin and adenylyl cyclase are predominantly hydrophobic, but specificity is enhanced by hydrogen bonds between O1 and O11 and C 1 and between the 7-acetyl and a serine at the ␤2Ј-␤3Ј turn on C 2 (927 and 942 on type I and II, respectively) ( Fig. 3D ). This is supported by structure-activity studies showing that 1-OH and 9-OH groups of forskolin and interaction between 7-acetyl groups of forskolin and S942 of IIC 2 are required for optimal activation of adenylyl cyclase by forskolin (Robbins et al., 1996; Yan et al., 1998) . One major surprise in the structure of adenylyl cyclase is the existence of a highly conserved hydrophobic pocket at the interface of C 1a /C 2a . Judged by primary sequence, this pocket in mammalian type IX enzyme is different from the other 
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at ASPET Journals on September 30, 2017 molpharm.aspetjournals.org eight types of mammalian adenylyl cyclases, and its homolog in fruit fly is such that it cannot be activated by forskolin (Premont, 1992; Iourgenko et al., 1997) . A single mutation (tyrosine to leucine) of mammalian type IX enzyme can confer both binding and activation by forskolin (Yan et al., 1998) . The sterically occluded nature of the binding site suggests that bulky molecules, such as proteins, are unlikely to bind to this site. Therefore, if a physiologically relevant activator of adenylyl cyclase exists that is directed to the forskolin binding site, it is likely to be a small molecule rather than a protein. Seamon and coworkers tested candidate molecules, but as yet no such small molecule has been identified (Laurenza et al., 1989) . Perhaps newly available genetic tools will facilitate a renewed search (Yan et al., 1998 ). An analogous compound could modulate the soluble guanylyl cyclase that is predicted to have only one GTP binding site and a deep hydrophobic pocket similar to the forskolin binding site of C 1a /C 2a . There is no report of forskolin activation of soluble Fig. 2 . Alignment of representative adenylyl and guanylyl cyclase sequences. Roman numerals, mammalian adenylyl cyclase types I, II, V, and IX from cow, rat, dog, and mouse, respectively, with accession numbers M25579, M80550, M88649, and U30602. sGC␣ and sGC␤ are bovine soluble guanylyl cyclase ␣1 and ␤1 subunits, accession numbers X54014 and Y00770. ACG and rGC1 are the germination-specific adenylyl cyclase of D. discoideum, and the photoreceptor specific membrane guanylyl cyclase-1, accession numbers M87278 and S74247. Secondary structures are shown for VC 1 (top) and IIC 2 (bottom). Unshaded boxes, residues that form hydrophobic pockets. Dark letters in lightly shaded boxes, residues with C 1 -like roles. White letters in darkly shaded boxes, residues with C 2 -like roles. The C 1 /C 2 heterodimer counterpart of the second C 2 homodimer forskolin site seems to be incapable of binding forskolin because of a replacement of the critical serine by an aspartic acid (Fig. 3E, ACI D354) . The aspartic acid precludes forskolin binding because it overlaps sterically with the 7-acetyl group. This aspartic acid in the C1 domain is critical for catalysis; therefore, the residue at this position probably is the most important difference between C 1 and C 2 domain sequences. Rotating the C 1 -C 2 heterodimer about the pseudo-2-fold axis relating the domains reveals that ATP and forskolin make many analogous interactions (Fig. 3, D and E). The forskolin O1 and adenine N6 both donate hydrogen bonds to an aspartic acid at the same position on ␤5 or ␤5Ј, respectively. This suggests that the forskolin binding Fig. 3 . Adenylyl cyclase structures. Green and red, C 1 and C 2 domains, respectively. Atoms are shown by small spheres colored white (carbon), blue (nitrogen), red (oxygen), yellow (sulfur), green (phosphorous), and purple (magnesium). A, Forskolin, but not G protein, activated conformation of the catalytic core of type I adenylyl cyclase. The C 1 and C 2 domains are modeled based on homology to IIC 2 homodimer crystal structure (Zhang et al., 1997b; Liu et al., 1997) . ATP has been docked into the active site in the anticonformation observed in the P-site inhibitor complex (Tesmer et al., 1997) , and two Mg 2ϩ ions are shown as observed for T7 polymerase (Doublie et al., 1998) . B, Crystal structure of VC 1 /IIC 2 heterodimer in the G s␣ -activated conformation (Tesmer et al., 1997) . G s␣ is omitted for clarity. MP-Forskolin, 7-desacetyl,7-(O-Nmethylpiperazino)-␥-butyryl forskolin. The active-site lid region that is ordered in this structure but not in the IIC 2 homodimer is marked. C, Crystal structure of G s␣ complexed with the VC 1 /IIC 2 heterodimer. Curved arrow at top, proposed direction of the G s␣ -induced rotation of C 1 relative to C 2 . The G s␣ binding site of adenylyl cyclase as defined by scanning mutagenesis (Yan et al., 1997a) In addition to their regulation by G s␣ and forskolin, mammalian adenylyl cyclases are subjected to complex regulation by other G proteins, Ca 2ϩ signals, and phosphorylation (Table 1). One of the major advances in understanding cAMPmediated signal transduction is in redefining the action of the members of the G i family (G i , G o , G z ) that can be activated by diverse hormones and neurotransmitters (i.e., adenosine, epinephrine, and cannabinoid). On activation, the G i family of proteins releases two potential regulators, G ␣ and G ␤␥ ; this process can be blocked by treatment with pertussis toxin. Traditionally, the activation by the G i family is viewed as producing only inhibition of adenylyl cyclase activity. Such inhibition does occur and can be mediated through the ␣ subunit of G i , G o , or G z or through G ␤␥ Taussig et al., 1994; Kozasa and Gilman, 1995) . For certain subtypes of adenylyl cyclases, such as type V and VI enzymes (predominantly expressed in heart), enzyme activity is inhibited by G i␣ and not altered by G ␤␥ (Taussig et al., 1994) . For type I enzyme, which is predominantly expressed in brain, where G o makes up to 1% of total membrane proteins, the activity of type I enzyme on stimulation of G ocoupled receptor is inhibited predominantly by G ␤␥ , and the ␣ subunit of G o facilitates this inhibition Taussig et al., 1994) . Characterizing the response from different isoform of adenylyl cyclase has led to the conclusion that the activation of G i /G o -coupled receptors also can lead to the activation, rather than inhibition, of adenylyl cyclase (Gao and Gilman, 1991; Yoshimura et al., 1996) . In brain and other tissues that express type II, IV, and VII enzymes, the activation of G i /G o releases G ␤␥ , which potentiates the enzymatic activity when the enzymes are simultaneously activated by G s␣ .
Where and how do G␤␥ and G i␣ bind and regulate adenylyl cyclase activity? The G ␤␥ binding site of type II adenylyl cyclase has been mapped to the C 2 -␣3 region (Chen et al., 1995) . G ␤␥ is likely to modulate type II enzyme by binding on only one domain (C 2a ) to affect its conformation, indirectly promoting optimal alignment at the catalytic site (Zhang et al., 1997b) . G ␤␥ must bind a different site of type I enzyme because the ␣3 region of type I enzyme is not conserved with that of type II enzyme and peptides from this region do not block a G ␤␥ -mediated response (Chen et al., 1995) . The action of G i␣ is not competitive with the binding of G s␣ (Taussig et al., 1994) . Because the major contacts between G s␣ and adenylyl cyclases (switch 2) also are conserved in G i␣ -based VC 1 /2C 2 /G s␣ structure, other regions, such as ␣3/␤5 of G s␣ , may play an crucial role in how G s␣ achieves the specificity over G i␣ (Tesmer et al., 1997; Skiba and Hamm, 1998) . The binding site for ␣ subunit of G i , G o , or G z has not been determined, but it is speculated to bind the ␣2/␣3 region of C 1a on the opposite site to G s␣ binding site (Yan et al., 1997a; Tesmer et al., 1997) . If this is the case, the binding site is close to the catalytic site and the binding of G ␣ proteins could disturb the optimal alignment, perhaps by blocking the "counterclockwise" rotation of C 1 ( Fig. 3C) .
Bioactive agonists also can activate G q -coupled receptors, leading to PKC activation, which in turn modulate adenylyl cyclases in an isotype-specific manner. In cells that have an overexpressed individual isoform of adenylyl cyclase, phorbol esters activate most of the adenylyl cyclases, including type II, III, V, and VII adenylyl cyclases (Yoshimura and Cooper, 1993; Jacobowitz and Iyengar, 1994; Kawabe et al., 1994) . Both type II and V adenylyl cyclases are phosphorylated by PKC␣ (Kawabe et al., 1994; Zimmermann and Taussig, 1996) . In vivo analysis using chimeric type I/II enzymes and mutational analysis has mapped a region on C 2a (1034 -1068) for PKC response, likely Thr1057 (Levin and Reed, 1995; Bol et al., 1997) . Thr1057 is close to the carboxyl-terminal lid that is disordered in IIC 2 , but it forms a catalytic lid over the active site in the heterodimer. The ability of this C 2 segment to form the catalytic lid could be altered by PKC phosphorylation of adenylyl cyclase (Fig. 3B) .
Intracellular Ca 2ϩ modulates diverse physiological responses; thus, it is not surprising that a Ca 2ϩ signal regulates the enzyme activity of adenylyl cyclases and that cAMP also modulates Ca 2ϩ release (Cooper et al., 1995) . Activation of calmodulin by Ca 2ϩ can activate type I and VIII enzymes directly and inhibit type III and type IX enzymes via calciumdependent calmodulin kinase II and calcineurin/PP2B, respectively Cali et al., 1994; Wei et al., 1996; Antoni et al., 1995) . An amphipathic region at the C 1b region of type I enzyme has been demonstrated to be involved in calmodulin binding and activation (Vorherr et al., 1993; Wu et al., 1993) . Currently, the precise mechanism of calmodulin activation is unknown. At physiological submicromolar levels, elevated intracellular Ca 2ϩ concentration inhibits type V and VI enzyme activity. This inhibition is more profound with entry from extracellular Ca 2ϩ than the release of Ca 2ϩ from the internal stores (Boyajian et al., 1991; Yoshimura and Cooper, 1992; Cooper et al., 1994) .Whether Ca 2ϩ modulates type V and VI enzymes directly or via a Ca 2ϩ binding protein remains elusive.
cAMP-mediated signaling is subject to desensitization after receptor activation. Substantial advances have been made in understanding desensitization at the receptor level, which involves G protein-coupled receptor kinase/arrestin, PKA, and receptor sequestration (Freedman, 1996, and references therein) . Such desensitization also occurs at the level of adenylyl cyclase exemplified by the study of type VI enzyme. Type VI enzyme can be desensitized via direct phosphorylation by PKA or PKC. PKA phosphorylation of type VI enzyme results in a 50% reduction in G s␣ -stimulated activity (Chen et al., 1997) . The phosphorylation site probably is Ser674 of the C 1b region because mutation of this site blocks the sensitivity of type VI enzyme to PKA (Chen et al., 1997) . This mechanism could explain the cAMP-dependent desensitization of glucagon stimulation in hepatocytes, but it does not occur in desensitization of adenosine receptor 2a in PC12 cells (Premont et al., 1992; Lai et al., 1997) . In PC12 cells, the predominant adenylyl cyclase is Ca 2ϩ -inhibited type VI enzyme, and adenylyl cyclase activity can be desensitized on the stimulation of A2a receptor, a G s -coupled receptor (Chern et al., 1995) . Interestingly, the desensitization of type VI enzyme in PC12 cells is cAMP independent and can be blocked by treatment with pertussis toxin but not by a selec- tive PKA inhibitor, H89 (Lai et al., 1997) . The desensitization in PC12 cells is mediated by a novel PKC (Ca 2ϩ independent) that phosphorylates and inhibits type VI enzyme (Lai et al., 1997) .
Catalytic Mechanism
Adenylyl cyclase converts ATP to cAMP and pyrophosphate without a covalently enzyme-bound intermediate (Eckstein et al., 1981; Dessauer and Gilman, 1996) . The turnover number of purified membrane-bound and soluble adenylyl cyclases ranges from 1 to 100 sec Ϫ1 and K m value for ATP of 30 -400 M. The forward reaction is sequential and bireactant in Mg 2ϩ -ATP and free Mg 2ϩ (Garbers and Johnson, 1975; Somkuti et al., 1982) . The mammalian adenylyl cyclase reaction proceeds by the inversion of configuration at the ␣-phosphate, consistent with a direct in-line displacement of pyrophosphate by attack of the 3Ј-OH on the ␣-phosphate (Eckstein et al., 1981) . The same inversion of configuration has been found for the homologous guanylyl cyclases (Koch et al., 1990) . Product release is random, with a preference for cAMP to dissociate first .
The three available molecular structures of adenylyl cyclase indicate that cyclase exists in at least three conformational states: (1) catalytically inactive IIC 2 , (2) G s␣ and forskolin bound IIC 2 complexed with VC 1 , and (3) G s␣ and forskolin bound IIC 2 complexed with VC 1 , adenosine analog, and pyrophosphate. These represent at least approximately ground state (E), substrate-free activated state (E*), and substrate/product bound state (E**) (Tesmer et al., 1997; Zhang et al., 1997b) . The enzyme cycle is likely to proceed as follows (Fig. 4) : the catalytic region of adenylyl cyclase (C 1 /C 2 interface) undergoes a conformational transition (E to E*) that is promoted by activators [e.g., G s␣ , forskolin, G protein ␤␥ (type II adenylyl cyclase) and Ca 2ϩ -calmodulin] or is blocked by inhibitors [e.g., G i␣ , G protein ␤␥ (type I adenylyl cyclase), free Ca 2ϩ ]. Although with ϳ10-fold lower affinity than for ATP, adenylyl cyclase does bind GTP, but it does not use GTP as a substrate. Thus, binding of substrate (ATP) must induce a further conformational change (E* to E**), which enables the enzyme to confirm its substrate (proofreading) and proceed through catalysis. After catalysis, the E* state could reform either before or after release of the product. Further structural characterization of the conformational changes on activation and during the enzyme reaction cycle will be critically important.
A class of adenosine analogs known as P-site inhibitors (due to the importance of an intact purine ring) has been used to probe the kinetic mechanism and active site structure of adenylyl cyclase (Johnson et al., 1989) . The potency of P-site inhibitors increases additively with 2Ј-or 5Ј-deoxy and 3Ј-phosphoryl (PPP Ͼ PP Ͼ P) moieties (Desaubry et al., 1996) . A point mutation at Lys923 of type I enzyme, a residue that is crucial in discrimination of ATP over GTP, affects the affinity for both ATP and P-site inhibitors . P-site inhibitors compete with the binding of nonhydrolyzable ATP and cAMP; the reaction product, PPi, enhances the binding of P-site inhibitors (Dessauer et al., 1997a) . Thus, P-site inhibitors seem to bind the cAMP site with high affinity. In steady state kinetic analyses, P-site inhibitors behave noncompetitively or noncompetitively with respect to MgATP. This apparent paradox can be resolved if P-site inhibitors and reaction products (cAMP and PPi) bind to a different adenylyl cyclase conformation (E**) than does ATP (E*) (Fig. 4) (Tesmer et al., 1997) .
Structure of the Active Site and Implication for Regulation
Catalysis requires at least three steps. ATP must bind in a conformation in which the 3Ј-hydroxyl closely approaches the ␣-phosphorous. The 3Ј OH of the ATP ribose must be activated for the attack on the 3Ј oxygen atom of the ␣-phosphate. The transition state for the displacement of pyrophosphate by the 3Ј oxygen atom must somehow be stabilized. Although the structure of a complex between adenylyl cyclase and ATP analog is not yet available, the C 1a /C 2a structure with P-site inhibitor/pyrophosphate complex and mutational data have provided an illuminating starting point for understanding the active site Liu et al., 1997; Tesmer et al., 1997; Yan et al., 1997b) (Fig. 3D) .
The active site of mammalian adenylyl cyclase is located in a deep cleft formed at the domain interface. It is composed primarily of ␤1, ␣1, the ␤2-␤3 turn of the C 1a domain, and ␣4Ј and ␤5Ј of the C 2a domain. Adenine binds in a hydrophobic pocket corresponding to part of one of the two forskolin sites on the IIC 2 homodimer (Liu et al., 1997; Tesmer et al., 1997) . Phosphate groups interact with an arginine side chain from each side of the cleft (Arg398 and Arg1011, AC1). The invariant Asn1025 (AC2) that is crucial for catalysis forms a watermediated interaction with the adenine in the structure of VC 1 /IIC 2 /G s␣ /P-site inhibitor complex. The carboxyl-terminal region (AC2 1058 -1071) forms a lid that is disordered in the IIC 2 homodimer but becomes ordered in VC 1 /IIC 2 /G s␣ complex (Tesmer et al., 1997; Zhang et al., 1997b) (Fig. 3, A and B) . Lys1067 (AC2) from this carboxyl-terminal "lid" is involved in binding ATP based on photoaffinity labeling and mutagenesis (Droste, 1996; . Hydrogen bonds between the adenine N6 and Asp1018 (AC2 numbering); and N1 and Lys938 (IIC 2 ) seem to confer specificity for adenine (Liu et al., 1997; Tesmer et al., 1997) . In guanylyl cyclases, these residues are replaced by a cysteine and a glutamic acid, respectively. Mutations of these two residues at retinal-specific guanylyl cyclase (ret GC-1) converts this enzyme into a highly active and fully regulated adenylyl cyclase (Tucker et al., 1998) .
A single Mg 2ϩ ion binds to pair of aspartates on C 1 (Tesmer et al., 1997) . The pair of aspartates is present in the overlaid structure of the palm domain of DNA polymerase I. The common Mg 2ϩ binding site substantiates a biochemically relevant similarity between the two. There are almost cer- (Garbers and Johnson, 1975) . Recent high-resolution structural analyses of DNA polymerase ␤ and DNA polymerases from T7 phage and Bacillus stearothermophilus reveal that the aspartic acid pair on polymerases is capable of binding two Mg 2ϩ ions (Sawaya et al., 1997; Doublie et al., 1998; Kiefer et al., 1998; Steitz, 1998) . Polymerase Mg 2ϩ ion B corresponds to the site observed in the P-site complex, except that it binds all three phosphate groups in a tridentate arrangement (Sawaya et al., 1997; Doublie et al., 1998; Steitz, 1998) . Polymerase metal ion A is thought to be responsible for catalysis because it interacts with the ␣-phosphate and the model-built 3Ј-OH (Doublie et al., 1998 , Kiefer et al., 1998 . The site corresponding to metal ion A on adenylyl cyclase is sterically compatible with Mg 2ϩ ion occupancy and seems to be the most likely site for the catalytic metal ion.
The four residues most clearly implicated in catalysis by mutational studies are closely juxtaposed in the vicinity of the metal ion and the reactive ribosyl and ␣-phosphate groups. Asn1025 and Arg1029 (Fig. 3D, AC1 1007 and 1011, respectively) are directly involved in catalysis based on mutagenesis and kinetic analysis (Yan et al., 1997b) . The Arg1029 guanidino group is poised in both VC I /IIC 2 /G s␣ / forskolin/P-site inhibitor crystal structure and IC 1 /IC 2 /ATP models to interact with the ␣-phosphate (Liu et al., 1997; Tesmer et al., 1997) . The best model for the ATP/cyclase complex shows the arginine interacting primarily with the bridging rather than nonbridging oxygen atoms, although the details remain to be established (Tesmer et al., 1997) . Asn1025 is close to the ␣-phosphate bridging oxygen atoms in current ATP complex models and may assist Arg1029 in stabilizing the transition state or the leaving group.
The identity of the catalytic base in the reaction is unresolved. Base catalysis could involve either substrate-assisted catalysis (Schweins et al., 1995) or a protein side chain. If any protein side chain acts as a catalytic base, it is most likely Asp354 (Liu et al., 1997; Tesmer et al., 1997) . Mutation of Asp354 in AC1 and its counterparts in guanylyl cyclases (Yuen et al., 1994; Thompson and Garbers, 1995) leads to enzymes that are completely inactive within the detection limits of the assays used, typically ϳ10 Ϫ3 of wild-type enzyme. The counterpart of this aspartic acid in B. Stearothermophilus DNA polymerase forms a hydrogen bond to the model-built 3Ј-end of the primer (Kiefer et al., 1998) , consistent with a role in deprotonating the 3Ј-OH. Mutation of the adjacent Asp310 reduces forskolin-stimulated activity by 900-fold (Liu et al., 1997) . The mutant phenotypes are consistent with a polymerase-like two-metal mechanism in which one metal activates the 3Ј-OH as well as coordinating the ␣-phosphate (Sawaya et al., 1997; Doublie et al., 1998; Steitz, 1998) .
The finding that the C 1 and C 2 domains juxtapose four critical catalytic residues, two each from C 1 and C 2 , provides the first opportunity to understand regulation of adenylyl cyclase in atomic detail. The precise alignment of C 1 and C 2 seems to be crucial to simultaneously enable metal and nucleotide binding and transition state stabilization. The physical association of C 1 and C 2 is an essential precondition for formation of the catalytic site, although it is not sufficient for activated catalysis by itself. In the absence of activators, soluble C 1 and C 2 domains have approximately micromolar affinity for one another. Their affinity for each other is greatly increased by the presence of forskolin, G s␣ , or both (Whisnant et al., 1996; Yan et al., 1996) . Forskolin acts as hydrophobic glue to attach the two domains, stabilizing the dimer by plugging a hydrophobic crevice (Zhang et al., 1997b) . G s␣ also bridges the two domains by binding to both C 1 and C 2 , explaining its ability to promote dimerization (Tesmer et al., 1997; Yan et al., 1997a) . Because C 1 and C 2 are covalently attached to each other in intact adenylyl cyclase, the dimerization-promoting effects of forskolin and G s␣ are probably less important in intact adenylyl cyclase than in the soluble system. Comparison of the crystal structure of the active VC 1 /IIC 2 /G s␣ with the IIC 2 homodimer suggests a possible structural mechanism that could underlie the allosteric activation of the preassembled dimer (Tesmer et al., 1997; Zhang et al., 1997b) . If the position the C 2 domain is fixed, the C 1 domain in the heterodimer is found to rotate ϳ7°" counterclockwise" (Tesmer et al., 1997) . This leads to small structural changes, typically Ͻ2 Å, in the positions of the main chain of active site residues. Although these changes may seem small, catalysis is so sensitive to precise stereochemical details that it is not unreasonable to imagine these small structural changes can lead to large changes in catalytic rate. We do not yet know how much of the small conformational change is due to G s␣ binding and how much is due to intrinsic differences between the heterodimeric and homodimeric AC structures. There still is no structure of a low activity conformation of adenylyl cyclase bound to ATP. The ␣1-␣2 loop of C 2 plays a critical role in this mechanism by communicating the structural change in the G s␣ binding groove outward, yet this loop is poorly conserved among different mammalian adenylyl cyclase isoforms. Mutational studies of this region will be important to dissect the mechanism of allosteric linkage. The activation mechanism must be considered tentative until this information becomes available.
Future Directions
Might intact mammalian adenylyl cyclase exist as a dimer? Target-size analysis suggested that the activated adenylyl cyclase is a dimer, whereas higher order complexes among receptor, G protein, and adenylyl cyclase exist at the resting state (Rodbell et al., 1981) . Hydrodynamic analysis of detergent solubilized or purified adenylyl cyclase also shows a possible monomer/dimer transition (Neer et al., 1984; Yeager et al., 1985) . A functional oligomer of type I enzyme has been observed using immunoprecipitation of recombinant type I enzyme and its mutant . Although the dimerization is unlikely to be involved in catalysis directly, based on the mutational and structural analysis, it could be crucial for the regulation or localization of the enzyme . Each isoform has its distinct pattern of expression, but significant overlap in the tissue distribution of different isotypes has been observed (i.e., in hippocampus and cerebral cortex). If certain heterodimers between two different isotypes of enzyme are allowed, dimerization of adenylyl cyclase would add a new dimension to the already complex regulation of adenylyl cyclase.
The molecular structure of adenylyl cyclase has provided a framework for understanding the mechanisms of catalysis and regulation in atomic detail for the first time. role of the hydrophobic pocket of adenylyl cyclase that binds forskolin? How does the binding of the regulators or phosphorylation outside the catalytic core (C 1a /C 2a ) (i.e., C 1b region) regulate adenylyl cyclase? What are the roles of transmembrane domains? The latter question has become more puzzling now that we know the soluble regions alone are capable of G s␣ -and forskolin-regulated catalysis. Membrane localization and coordination of C 1a /C 2a interaction are the clearcut roles for transmembrane domains, but why are there 12 when 1 or 2 would have sufficed? A role in transmembrane transport was suggested by the topological similarity to other transporters (Krupinski et al., 1989) , but efforts by several workers have thus far failed to demonstrate such a function. If the accumulation of data concerning adenylyl cyclase continues with the same exponential rise seen over the past 10 years, we can hope that answers to these questions should be available in the near future.
